CCDC85C suppresses colorectal cancer cells proliferation and metastasis through activating GSK-3β and promoting β-catenin degradation
Cellular Signalling · 2023
DOI: 10.1016/j.cellsig.2023.110799 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2023. Verfasst von Wenlong Hu und 11 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College, Nanjing University of Chinese Medicine, No. 155, Hanzhong Road, Qinhuai District, Nanjing, Jiangsu Province, Chin…. Hauptthemen laut MEDLINE: beta Catenin, Colorectal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Coiled-coil domain-containing 85C (CCDC85C) is a member of the DIPA family and contains a pair of conserved coiled-coil motifs, which was found to be related to a therapeutic target for colorectal cancer, however, its biological effects require further elucidation. This study aimed to determine the effect of CCDC85C on Colorectal Cancer (CRC) progression and to explore the related mechanism. pLV-PURO plasmid was used to construct CCDC85C-overexpressing cells while CRISPR-CasRx was used to construct CCDC85C knockdown cells. Effects of CCDC85C on cell proliferation, cycle and migration were examined using cell counting kit-8 assay, flow cytometry, wound healing assay and transwell assay. Immunofluorescence staining, immunoprecipitation, Western blot, co-immunoprecipitation and qPCR were performed to explore the mechanism. The overexpression of CCDC85C inhibited the proliferation and migration of HCT-116 and RKO cells in vitro and in vivo, but its knockdown promoted the proliferation of HCT-116 and RKO cells in vitro. Moreover, co-immunoprecipitation experiment confirmed that CCDC85C binding with GSK-3β in RKO cells. Excess CCDC85C promoted phosphorylation and ubiquitination of β-catenin. Our results suggested that CCDC85C binds to GSK-3β to promote its activity and facilitates ubiquitination of β-catenin. β-catenin degradation is responsible for the inhibitory effect of CCDC85C on CRC cell proliferation and migration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Clinical Medical College, Nanjing University of Chinese Medicine, No. 155, Hanzhong Road, Qinhuai District, Nanjing, Jiangsu Province, China; Jiangsu Collaborative Innovation Center of Traditional Chinese Medi…
- Institute of Literature in Chinese Medicine, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Qixia District, Nanjing, Jiangsu Province, China.
Zitieren
APA
Hu, W., Shen, J., Tao, Y., Dong, D., Lu, S., Li, L., Sun, D., Fan, M., Xu, C., Shen, W., Yu, C., & Cheng, H. (2023). CCDC85C suppresses colorectal cancer cells proliferation and metastasis through activating GSK-3β and promoting β-catenin degradation. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2023.110799
Vancouver
Hu W, Shen J, Tao Y, Dong D, Lu S, Li L, et al. CCDC85C suppresses colorectal cancer cells proliferation and metastasis through activating GSK-3β and promoting β-catenin degradation. Cellular Signalling. 2023. doi:10.1016/j.cellsig.2023.110799
BibTeX
@article{Hu2023,
author = {Hu, Wenlong and Shen, Jie and Tao, Yu and Dong, Dan and Lu, Sicheng and Li, Liu and Sun, Dongdong and Fan, Minmin and Xu, Changliang and Shen, Weixing and Yu, Chengtao and Cheng, Haibo},
title = {CCDC85C suppresses colorectal cancer cells proliferation and metastasis through activating GSK-3β and promoting β-catenin degradation},
journal = {Cellular Signalling},
year = {2023},
doi = {10.1016/j.cellsig.2023.110799}
}
EUVIMED